Smurfit Westrock unveils new clinical packaging facility at Dublin Airport
pharmafile | November 13, 2025 | News story | Medical Communications | Dublin, Smurfit Westrock, clinical packaging facility
Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare.
Over €40m was invested in the brand-new site, which will provide packaging solutions for clinical trials and regulated pharma packaging. The facility’s design and its operational processes reflect those of a pharmaceutical manufacturing environment, with patient focus at the core.
Packaging plays a critical role in the success of clinical healthcare trials. Smurfit Westrock provides an industry-leading range of clinical trial packaging solutions designed to improve patient adherence and provide enhanced data.
Speaking at the opening, Tony Smurfit, President and CEO of Smurfit Westrock, said: “We are immensely proud of this groundbreaking and beautifully designed new plant. The packaging solutions that are designed and manufactured here will contribute significantly to the next generation of life-saving medicines.”
Strategically located adjacent to Dublin Airport, the facility houses a 170-person team of highly skilled designers, operators and support functions. It also has an Experience Centre that brings to life the extensive capabilities for visitors’ individual requirements.
With the new site ideally situated to serve Europe, Smurfit Westrock’s world-leading service in the adherence and clinical trials packaging space is also supported by its sites in Kunshan, China and Mebane, North Carolina in the US.
Smurfit Westrock is a leading global provider of paper-based packaging solutions, with approximately 100,000 employees across 40 countries.
Related Content
Zymeworks to open new EU HQ in Dublin, Ireland
Canadian biotech company Zymeworks has announced plans to open its new Clinical and Regulatory EU …
Jazz Pharmaceuticals to expand Irish workforce across Dublin, Athlone sites
Jazz Pharmaceuticals has announced its intention to expand its staff numbers at two of its …
Takeda to create 70 jobs with €25m Dublin investment
Takeda has announced its investment of €25 million to construct a new “modular cell therapy …
